TODAY : Monday, 21 April 2025
Code
DGNS
Title
PT Diagnos Laboratorium Utama Tbk
Address
Head Office:
Address:Gedung Graha Anam 2th Floor, Jl. Teuku Cik Ditiro No.11 A,B,C
Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat 10350
Phone:(021) 3193 1883
Fax:-
E-mail:corsec@diagnos.co.id
Website:www.diagnos.co.id
Background

The Company’s scope of activities is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouse, eye banks, sperm bank and blood banks, organ transplant banks and other medical support services.
Business cp product

The Company’s scope of activities is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouse, eye banks, sperm bank and blood banks, organ transplant banks and other medical support services.
Subsidiary affiliation
Commissioners
President Commissioner: Ivan Rizal Sini
Commissioner: Nurhadi Yudiyantho
Independent Commissioner: Martinus Eliatulo Zega
Per 30 Sep 2023
Directors
President Director: Ir. Mesha Rizal Sini
Director: Dennis Jacobus
DirectorRenobulan Rizal Sini Suheimi
Director: Fergus Richard
Director: Dilly Dwiasri
Per 30 Sep 2023
Underwriter
PT. Mirae Asset Sekuritas Indonesia
Share registrar
PT. Adimitra Jasa Korpora
Share holders
ShareholdersShares%
PT Bunda Investama Indonesia48500000038.8
PT Bundamedik51500000041.2
Public25000000020
As of Sep 30, 2023
History stocks

Type of ListingDatePrice## of SharesTotal Listed Shares

IPO @ Rp 20015-Jan-2021252500000001250000000
Other infos

Created date
2023-11-09 11:06:38
Revised date
2023-11-09 11:06:38
Finance
 
PT Diagnos Laboratorium Utama Tbk
 
2023, 2022, 2021, 2020, 2019, 2018, 2017,
Financial Statetment Date
Fiscal Year Ends
Months Covered in Income St
 
Summary Covered in Income St
Cash and Cash Equivalents
Receivables
Inventories
Current Assets
Fixed Assets
Other Assets
Non Current Assets
Total Assets
Current Liabilities
Longterm Liabilities
Total Liabilities
Authorized
Paid-up Capital
Par Value
Paid-up Capital Shares
Retained Earnings
Total Equity
Minority Interest
 
Summary of Income Statement
Total Sales
Cost of Good Sold
Gross Profit
Operating Profit
Other Income
Earning Before Tax
Tax
Net Income
Close Price
 
Per Share Data (Rp)
Eps (annualized)
Book Value
 
Financial Ratios
Debt Equity Ratio (X)
Roa(%)
Roe(%)
Npm(%)
Opm(%)
Gross Profit Margin (%)
Total Assets Turnover
 
Cash Flow
CF from Operation Activities
CF from Investing Activities
CF from Financing Activities
Net Increase in Cash & Cash Equivalent
Cash & Cash Equivalent at Beginning of the Year
Cash & Cash Equivalent at The End of the Year
2020-12-31 2020-06-30
Dec Dec
12 6
 
 
16,538,270.35 11,150,649.36
81,273,273.43 16,343,815.21
5,812,860.44 4,326,313.55
105,154,066.43 32,980,307.38
20,107,634.92 17,436,822.69
0.00 0.00
27,420,580.73 41,687,641.26
132,574,647.16 74,667,948.64
30,611,947.54 16,939,621.61
2,896,318.47 3,056,118.39
33,508,266.02 19,995,740.00
4,000,000.00 500,000.00
25,000,000.00 25,000,000.00
25.00 50.00
1,000,000.00 500,000.00
74,205,053.03 29,719,399.32
99,066,381.14 54,672,208.64
0.00 0.00
 
 
183,170,680.32 44,330,587.49
96,460,973.63 25,201,214.95
86,709,706.69 19,129,372.54
69,167,721.39 12,100,699.24
-2,192,643.64 -1,270,704.19
66,975,077.75 10,829,995.04
14,288,539.41 2,629,110.41
52,686,538.34 8,200,884.63
0.00 0.00
 
 
52.69 32.80
99.07 109.34
 
 
0.34 0.37
39.74 21.97
53.18 30.00
28.76 18.50
37.76 27.30
47.34 43.15
1.38 0.59
 
 
26,228,470.97 754,296.42
-8,150,424.71 9,260,254.58
-2,933,169.33 -257,255.94
15,144,876.93 9,757,255.94
1,393,393.42 1,393,393.42
16,538,270.35 11,150,649.36